Literature DB >> 2568655

Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.

R Dall'Olio1, P Roncada, A Vaccheri, O Gandolfi, N Montanaro.   

Abstract

Several studies have indicated that the D2 dopamine receptors mediate the antidopaminergic activity of the neuroleptics; nevertheless, the selective blocker (-)-sulpiride weakly inhibits dopamine-mediated behaviour. The present study investigated whether the concomitant injection of doses of the D1 antagonist SCH 23390, which by themselves are without effect, would enable (-)-sulpiride to express fully neuroleptic activity in the rat. The benzamide YM 09151-2 that strongly inhibits dopamine-mediated behaviour was also studied. Rats receiving different doses of (-)-sulpiride, YM 09151-2 and SCH 23390 given alone or in combination were tested for exploratory activity, apomorphine-induced stereotyped behaviour and hyperactivity elicited by the D2 agonist LY 171555. When given alone, (-)-sulpiride (10, 20 and 40 mg/kg IP) had no effect on exploratory activity and stereotypy. When (-)-sulpiride was administered in combination with an ineffective dose of SCH 23390 (5 micrograms/kg) both responses were significantly inhibited. The combined administration of subthreshold doses of (-)-sulpiride (2.5 mg/kg) and SCH 23390 (2.5 micrograms/kg) significantly inhibited hypermotility induced by LY 171555. Moreover, the combined administration of ineffective doses of YM 09151-2 with subthreshold doses of SCH 23390 strongly inhibited all the behavioural responses. The results indicate that SCH 23390 allowed (-)-sulpiride to exhibit a wider spectrum of neuroleptic activity and potentiated the antidopaminergic activity of YM 09151-2.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2568655     DOI: 10.1007/BF00451685

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Changes in behavioural responses to the combined administration of D1 and D2 dopamine agonists in normosensitive and D1 supersensitive rats.

Authors:  R Dall'Olio; O Gandolfi; A Vaccheri; P Roncada; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Science       Date:  1976-04-30       Impact factor: 47.728

3.  Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.

Authors:  M Mashurano; J L Waddington
Journal:  Neuropharmacology       Date:  1986-08       Impact factor: 5.250

4.  A behavioural and biochemical comparison of dopamine receptor blockade produced by haloperidol with that produced by substituted benzamide drugs.

Authors:  P Jenner; A Clow; C Reavill; A Theodorou; C D Marsden
Journal:  Life Sci       Date:  1978-08-14       Impact factor: 5.037

5.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.

Authors:  G R Breese; R A Mueller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

6.  Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists.

Authors:  A G Molloy; K M O'Boyle; M T Pugh; J L Waddington
Journal:  Pharmacol Biochem Behav       Date:  1986-07       Impact factor: 3.533

7.  Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.

Authors:  A V Christensen; J Arnt; J Hyttel; J J Larsen; O Svendsen
Journal:  Life Sci       Date:  1984-04-16       Impact factor: 5.037

8.  Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.

Authors:  N Montanaro; R Dall'Olio; O Gandolfi; A Vaccheri
Journal:  Eur J Pharmacol       Date:  1982-06-16       Impact factor: 4.432

9.  Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

Authors:  M T Pugh; K M O'Boyle; A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

10.  Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.

Authors:  J Arnt
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

View more
  3 in total

1.  Repeated treatment with (-)-sulpiride plus a low dose of SCH 23390 displays wider neuroleptic activity without inducing dopaminergic supersensitivity.

Authors:  R Dall'Olio; O Gandolfi; P Roncada; A Vaccheri; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  The NMDA positive modulator D-cycloserine potentiates the neuroleptic activity of D1 and D2 dopamine receptor blockers in the rat.

Authors:  R Dall'Olio; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.

Authors:  R Dall'Olio; O Gandolfi; N Montanaro
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.